Arcturus Therapeutics ARCT 深 滬
等待開盤 09-17 09:30:00 美东时间
15.64
-0.200
-1.26%
華盛通- 最 高16.3768
- 今 開16.00
- 成交量 62.17万股
- 最 低 15.04
- 昨 收 15.84
- 總市值 4.45亿
- 52周最高 24.17
- 市盈率 靜 --
- 換手率 2.19%
- 52周最低 5.50
- 委 比 -45.25%
- 總股本 2842.31万
- 歷史最高 129.71
- 量 比 0.95
- 振 幅 8.44%
- 歷史最低 4.11
- 每 手 1
- 風險率 4.43%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多National Beverage Posts Downbeat Q1 Results, Joins Zumiez, Adobe And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining around 250 points on Friday. Shares of National Beverage Corp (NASDAQ:FIZZ) fell in pre-market trading following downbeat first-quarter results. National Beverage reported quarterly earnings of 50 cents per share which missed ...
09-11 20:04
美股牛股 | GoPro获YouTube顶流入股暴升40%；Moderna劲升9.9%，mRNA重磅试验再传捷报；爱迪生国际升近9%
GoPro获YouTube顶流入股暴升40%；Moderna劲升9.9%，mRNA重磅试验再传捷报；爱迪生国际升近9%，监管预期改善推动估值修复>>
09-02 18:51
Arcturus, Moderna fall after BioNTech's cancer vaccine setback
Messenger RNA drug developers Arcturus Therapeutics (ARCT) and Moderna (MRNA) traded lower on Friday after BioNTech (BNTX) decided to halt a mid-stage trial for its mRNA-based cancer vaccine BNT122 de...
08-29 02:08
Arcturus Therapeutics shares are trading higher. The company announced it will present data on ARCT-810 mRNA therapy in Ornithine Transcarbamylase Deficiency at the 2026 SSIEM Annual Symposium.
Arcturus Therapeutics shares are trading higher. The company announced it will present data on ARCT-810 mRNA therapy in Ornithine Transcarbamylase Deficiency at the 2026 SSIEM Annual Symposium.
08-26 00:24
美股牛股 | 比特币一度逼近8万美元，加密股集体爆发，StablecoinX暴涨85%、嘉楠科技涨逾27.3%；mRNA赛道迎来资金爆炒！Arcturus飙涨22%
比特币一度逼近8万美元，带动加密概念股集体走强，StablecoinX暴涨85.2%，嘉楠科技涨27.3%。Moderna临床利好提振mRNA板块，Arcturus大涨22.4%。
08-24 18:19
美股牛股 | Moderna狂飙177%！美银火速将其目标价翻两番；油气股SOC升近20%
Moderna狂飙177%！美银火速将其目标价翻两番，TEM、BNTX受利好分别升24%、22%；；油气股SOC升近20%，法院裁定其加州管道重启工作将继续进行>>
08-20 16:20
Arcturus Therapeutics Earnings Call Balances Progress, Pressure
Arcturus Therapeutics (($ARCT)) has held its Q2 earnings call. Read on for the ...
08-20 08:28
Arcturus Therapeutics To Present At Canaccord Annual Growth Conference August 11
Webcast link can be found under Investor Relations/Events section of Arcturus’ website.
07-21 04:06
Arcturus Picks Thermo Fisher To Support Cystic Fibrosis Therapy
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) is collaborating with Thermo Fisher Scientific Inc. (NYSE:TMO) to support the Phase 3 development and potential commercialization of ARCT-032, the company’s investigational messenger RNA therapy for cystic fibrosis. Read Also: Thermo Fisher Flags 'Mo...
07-02 23:32
